Н.С. Сметанина
- Genetics top 5%
- Hemoglobinopathies and Related Disorders 28
- Myeloproliferative Neoplasms: Diagnosis and Treatment 5
- Hematology top 5%
- Blood groups and transfusion 17
- Iron Metabolism and Disorders 16
-
- Erythrocyte Function and Pathophysiology 11
-
- RNA modifications and cancer 6
- Cancer-related gene regulation 5
-
- Blood properties and coagulation 4
- Co-authors
- T. P. MolchanovaT. H. J. HuismanTitus H.J. HuismanLisha GuAdekunle AdekileE. BaysalNicolas LévyAlexey Maschan
- Journals
- Blood (3 papers)Biochemical and Biophysical Research Communications (1 paper)British Journal of Haematology (1 paper)
- Partner nations
- RussiaUnited StatesKuwait
In The Last Decade
Н.С. Сметанина
44 papers receiving 271 citations
Peers
Comparison fields: 5 of 41
- Genetics 187
- Hematology 155
- Pediatrics, Perinatology and Child Health 51
- Cell Biology 25
- Physiology 33
Countries citing papers authored by Н.С. Сметанина
This map shows the geographic impact of Н.С. Сметанина's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Н.С. Сметанина with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Н.С. Сметанина more than expected).
Fields of papers citing papers by Н.С. Сметанина
This network shows the impact of papers produced by Н.С. Сметанина. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Н.С. Сметанина. The network helps show where Н.С. Сметанина may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Н.С. Сметанина, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2022 | 3 | |
| 3 | 2022 | 2 | |
| 4 | 2021 | 0 | |
| 5 | 2021 | 0 | |
| 6 | 2020 | 0 | |
| 7 | 2019 | 8 | |
| 8 | 2019 | 7 | |
| 9 | 2019 | 0 | |
| 10 | 2018 | 0 | |
| 11 | 2017 | 5 | |
| 12 | 2017 | 2 | |
| 13 | 2016 | 1 | |
| 14 | 1998 | 5 | |
| 15 | 1997 | 8 | |
| 16 | 1997 | 27 | |
| 17 | 1997 | 1 | |
| 18 | 1996 | 6 | |
| 19 | 1996 | 5 | |
| 20 | 1995 | 10 |
About Н.С. Сметанина
Н.С. Сметанина is a scholar working on Genetics, Hematology and Physiology, having authored 56 papers that have together received 279 indexed citations. Recurring topics across this work include Hemoglobinopathies and Related Disorders (28 papers), Blood groups and transfusion (17 papers), Iron Metabolism and Disorders (16 papers), Erythrocyte Function and Pathophysiology (11 papers), RNA modifications and cancer (6 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers), Cancer-related gene regulation (5 papers) and Blood properties and coagulation (4 papers). The work is most often cited by research in Genetics (187 citations), Hematology (155 citations) and Pediatrics, Perinatology and Child Health (51 citations). Н.С. Сметанина has collaborated with scholars based in Russia, United States and Kuwait. Frequent co-authors include T. P. Molchanova, T. H. J. Huisman, T. H. J. Huisman, Titus H.J. Huisman, T. H. J. Huisman, Lisha Gu, Adekunle Adekile, E. Baysal, Nicolas Lévy and Alexey Maschan. Their work appears in journals such as Blood, Biochemical and Biophysical Research Communications and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.